OpenAI researcher Miles Wang plans AI drug discovery startup valued at $2 billion

OpenAI researcher Miles Wang is preparing to start a new venture. He is in talks to launch an AI-driven drug discovery startup. The company is projected to be valued at $2 billion. The venture will apply artificial intelligence to pharmaceutical research. It reflects growing interest in AI applications for drug development. The valuation signals strong investor confidence in the concept. The startup could accelerate the discovery of new medicines. Further announcements on funding and partnerships are expected.